In vivo studies with antisense oligonucleotides
- 31 January 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (1) , 12-18
- https://doi.org/10.1016/s0165-6147(96)01002-4
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Biodegradable polymer matrices for the sustained exogenous delivery of a biologically active c-myc hammerhead ribozymeInternational Journal of Pharmaceutics, 1996
- Antitumor Effect of c-myc Antisense Phosphorothioate Oligodeoxynucleotides on Human Melanoma Cells In Vitro and in MiceJNCI Journal of the National Cancer Institute, 1996
- Novel enzymatic and immunological responses to oligonucleotidesToxicology Letters, 1995
- The therapeutic potential of antisense oligonucleotidesBioEssays, 1995
- Transient Decrease in High Blood Pressure by In Vivo Transfer of Antisense Oligodeoxynucleotides Against Rat AngiotensinogenHypertension, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.Journal of Clinical Investigation, 1991
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991